This headline, recently seen in the news, reports on a new journal publication which looked at a large number of previous studies. The researchers bought together data from studies of people with canc ...
News
Guidance on COVID-19 Vaccination
The Add-Aspirin Trial Management Group encourages everyone on the Add-Aspirin trial to have a Covid vaccine if they are advised to do so by their hospital doctor or GP. Add-Aspirin trial participants ...
Re-opening Trial Recruitment in the UK and ROI
We’re pleased to announce that we are now in a position to re-open trial recruitment in the UK and ROI in those centres that have the capacity to begin registering patients again. Please refer to the ...
Updated guidance on use of NSAIDs and COVID-19
There have been a number of reports, particularly on social media, suggesting that non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, could worsen symptoms of COVID-19. In response to ...
Suspension of Registrations to the Add-Aspirin Trial
Registrations at all UK and ROI sites will be suspended from 17:00 on Thursday 9th April. Randomisation of patients registered for the run-in period by this date can proceed as per guidance found here ...
News and Resources